Katherine E. Warren, MD

Clinical Director, Pediatric Neuro-Oncology


Professor of Pediatrics, Harvard Medical School
Office Phone: 617-632-4907
Appointment Phone: 617-632-2680
Fax: 617-632-4897


Treatment Centers
Clinical Interests
Diffuse gliomas, DIPG, Protocol development, Survivorship


Dana-Farber/Boston Children's Cancer and Blood Disorders Center
450 Brookline Avenue
Boston, MA  02215


Board Certifications
National Cancer Institute, Pediatric Oncology Research
Children's National Medical Center, Pediatrics
Medical School
Tufts University School of Medicine, 1990
Dr. Warren is an internationally recognized expert in pediatric neuro-oncology. She was appointed Clinical Director of Pediatric Neuro-Oncology at Dana-Farber/Boston Children's in 2019 and was previously Senior Investigator and head of the Neuro-Oncology Section in the Pediatric Oncology branch of the National Cancer Institute where she worked for more than 25 years. Her major focus is developing new therapeutics to improve the outcome and quality of life for children with CNS tumors. Her work focuses on rational, pharmacokinetic-based drug development for children with brain tumors, and she is a leading innovator in developing new means of drug delivery. Her clinical trials have led the field in exploring new approaches for the treatment of children with these diseases. Dr. Warren has extensive experience in pharmacology, neuro-imaging, and clinical trial design and incorporates each of these into her research. She has led a number of clinical trials, including single institution, multi-institution, national consortium, and international trials.

Dr. Warren currently serves as the chair of RAPNO (Response Assessment in Pediatric Neuro-Oncology), a member of the NCI Brain Malignancy Steering Committee, NCI Clinical Trials, and Translational Research Advisory Committee Ad hoc Working Group on Glioblastoma, and is a steering committee member for the DIPG Registry. She has served on numerous national and international scientific committees and advisory boards.

Video: Meet Katherine E. Warren, MD

Appointments & Second Opinions

Speak with one of our New Patient Coordinators to schedule an appointment, refer a patient or request a second opinion. In urgent cases, we can typically see new patients within 24 hours.

Clinical Trials

Search our wide range of clinical trials, including novel therapies, immunotherapy and personalized therapy.callout bg

Harvard Medical Affiliate

HMS Callout FAD 

As a teaching affiliate of Harvard Medical School, our physicians are passing on their expertise to the next generation of pediatric hematologists and oncologists.